Literature DB >> 16160874

Right ventricular expression of extracellular matrix proteins, matrix-metalloproteinases, and their inhibitors over a period of 3 years after heart transplantation.

D J Schupp1, B P Huck, J Sykora, C Flechtenmacher, M Gorenflo, A Koch, F-U Sack, M Haass, H A Katus, H E Ulmer, S Hagl, H F Otto, P A Schnabel.   

Abstract

Fibrillar collagens I and III, nonfibrillar collagen IV, and the glycoproteins fibronectin and laminin, are elements of the myocardial extracellular matrix (ECM). Alterations in the normal concentrations and ratios of these elements may reflect remodeling in response to physiologic stress. In the case of patients' post-heart transplantation (HTx), specific patterns of alteration may herald myocardial dysfunction. Right ventricular biopsies were taken from the same 28 HTx patients before implantation and 1 week, 2 weeks, and 1, 2, and 3 years after HTx. The above-noted five ECM proteins, six matrix metalloproteinases (MMPs) and two of their tissue inhibitors (TIMPs) were detected by immunohistochemistry and scored as cells per square millimeter or semiquantitatively. The total connective tissue fibers were detected by connective tissue stain and morphometry. Variations in these ECM components were followed in the same patient cohort over 3 years. In summary, during the first 2 weeks after HTx, a predominant increase in connective tissue occurred. Increases in MMP-8 and MMP-9 were found. By 3 years after transplantation, there was a decrease of connective tissue fibers and a significant reduction of all ECM components and an increase in MMPs and TIMPs. These findings may reflect a pattern of remodeling specific to the transplanted heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160874     DOI: 10.1007/s00428-005-0050-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  44 in total

1.  Matrix metalloproteinases: not-so-innocent bystanders in heart failure.

Authors:  R T Lee; P Libby
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas.

Authors:  Akira Kabashima; Takashi Yao; Keizo Sugimachi; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

3.  Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.

Authors:  J T Peterson; H Li; L Dillon; J W Bryant
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

4.  Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.

Authors:  C V Thomas; M L Coker; J L Zellner; J R Handy; A J Crumbley; F G Spinale
Journal:  Circulation       Date:  1998-05-05       Impact factor: 29.690

5.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.

Authors:  L E Rohde; A Ducharme; L H Arroyo; M Aikawa; G H Sukhova; A Lopez-Anaya; K F McClure; P G Mitchell; P Libby; R T Lee
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

Review 6.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

7.  Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.

Authors:  Y Y Li; Y Q Feng; T Kadokami; C F McTiernan; R Draviam; S C Watkins; A M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

8.  Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.

Authors:  F G Spinale; M L Coker; C V Thomas; J D Walker; R Mukherjee; L Hebbar
Journal:  Circ Res       Date:  1998-03-09       Impact factor: 17.367

9.  The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease.

Authors:  D G Sweet; A E Curley; E Chesshyre; J Pizzotti; M S Wilbourn; H L Halliday; J A Warner
Journal:  Acta Paediatr       Date:  2004-06       Impact factor: 2.299

10.  Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.

Authors:  Y Y Li; A M Feldman; Y Sun; C F McTiernan
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

View more
  4 in total

1.  Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.

Authors:  Marcus Franz; K Grün; P Richter; B R Brehm; M Fritzenwanger; K Hekmat; D Neri; J Gummert; H R Figulla; H Kosmehl; A Berndt; A Renner
Journal:  Histochem Cell Biol       Date:  2010-10-08       Impact factor: 4.304

2.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

Review 3.  Right ventricular failure and pathobiology in patients with congenital heart disease - implications for long-term follow-up.

Authors:  Doreen Köhler; Raoul Arnold; Tsvetomir Loukanov; Matthias Gorenflo
Journal:  Front Pediatr       Date:  2013-11-19       Impact factor: 3.418

Review 4.  Aging, exercise, and extracellular matrix in the heart.

Authors:  Hyo-Bum Kwak
Journal:  J Exerc Rehabil       Date:  2013-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.